At CSL Behring, we recognize the importance of conducting our operations in an environmentally responsible manner.
Energy, water and other natural resources are essential inputs to the production of our therapies. Our manufacturing processes, and the packaging and transport of our medicines, generate greenhouse gas emissions and waste. We are committed to minimizing these environmental impacts without compromise to the safety, quality and affordability of our medicines.
CSL Behring’s commitment to the environment is set by the Board and articulated in our Code of Responsible Business Practice. Our Global Environment, Health, Safety & Sustainability Policy and Statement on Climate Change provide further guidance to management and staff. These are critical elements of our enterprise-wide Environment, Health, Safety and Sustainability (EHS2) Management System.
We measure our environmental impact and intensity performance against a number of key indicators. Performance trends for our manufacturing sites are detailed in the Environment section of Our Corporate Responsibility Report.
CSL Behring’s Australian operations are also a signatory to the Australian Packaging Covenant (APC). As part of our commitment to the goals and principles of the APC, an action plan has been developed with actions that will integrate the principles sustainable packaging and product stewardship into packaging design process. Access to additional information can be found on the APC website - www.packagingcovenant.org.au.
Read the CSL Behring APCO 2021 Annual Report & Action Plan.